Cargando…
Venlafaxine antagonizes the noradrenaline-promoted colon cancer progression by inhibiting the norepinephrine transporter
Epidemiological studies have demonstrated that the use of antidepressants is associated with a decreased risk of colorectal cancer (CRC); however, the mechanisms behind this association are yet unknown. Adrenergic system contributes to the stress-related tumor progression, with norepinephrine (NE) m...
Autores principales: | Zhang, Huahua, Han, Jiming, Zhang, Jing, Miao, Jiyu, Li, Fang, Tang, Kaijie, Zhou, Kai, Duan, Baojun, Li, Wen, Cheng, Jing, Sun, Ying, Hou, Ni, Huang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167232/ https://www.ncbi.nlm.nih.gov/pubmed/37156838 http://dx.doi.org/10.1038/s41420-023-01447-5 |
Ejemplares similares
-
Norepinephrine transporter promotes the invasion of human colon cancer cells
por: Zhang, Huahua, et al.
Publicado: (2020) -
Norepinephrine‐CREB1‐miR‐373 axis promotes progression of colon cancer
por: Han, Jia, et al.
Publicado: (2020) -
TDG suppresses the migration and invasion of human colon cancer cells via the DNMT3A/TIMP2 axis
por: Miao, Jiyu, et al.
Publicado: (2022) -
Noradrenaline transporter PET reflects neurotoxin-induced noradrenaline level decrease in the rat hippocampus
por: Sakai, Takayuki, et al.
Publicado: (2023) -
Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder
por: Aldosary, Fahad, et al.
Publicado: (2021)